CompanyConverge Bio
IndustryBiotechnology Research
Founded2024
Monthly Web Traffic564 visits/mo
InvestorsBessemer Venture Partners
One payment, no subscription
Get the founder's verified email
Plus every other recently funded founder — verified emails, funding, and investors. Pay $49 once.
Get Lifetime Access →About Converge Bio
Converge Bio is accelerating drug development through GenAI-powered innovations in discovery, molecule design and manufacturing to create the therapies of tomorrow, today.
- How much did Converge Bio raise?
- Converge Bio raised $25M in a Series A round on Jan 13, 2026. Investors include Bessemer Venture Partners.
- Who founded Converge Bio?
- Founder information for Converge Bio is available on JustRaised.
- How do I contact the founders of Converge Bio?
- Verified founder emails and LinkedIn profiles for Converge Bio are unlocked with JustRaised lifetime access — a single $49 payment.
